Pinealon (20mg)
Pinealon is a synthetic tripeptide (Glu-Asp-Arg) from the Khavinson peptide research program, investigated for neuroprotective effects and modulation of cognitive and pineal-axis function.
About Pinealon
Pinealon is a synthetic tripeptide (Glu-Asp-Arg) developed in the Russian peptide research program led by Dr. Vladimir Khavinson. Unlike Epithalon, which is studied primarily for longevity and telomere biology, Pinealon research has focused on neuroprotection, cognitive function, and modulation of pineal-axis activity.
Mechanism in Research Literature
Research on Pinealon has documented:
- Entry into the central nervous system via small-peptide transport
- Modulation of gene expression in neuronal cell models
- Antioxidant effects in brain tissue
- Effects on neurotransmitter synthesis pathways
- Modulation of pineal function and melatonin-related signaling
Research Context
Pinealon has been investigated in studies exploring:
- Neuroprotection in age-related cognitive decline models
- Cognitive function research including attention and memory
- Pineal-axis biology and circadian regulation
- Khavinson short-peptide pharmacology
- Neurotransmitter system modulation
Related Research Peptides
Pinealon appears in literature alongside other Khavinson peptides (Epithalon, NA Epithalon), neurally-active compounds (DSIP), and broader longevity peptides (NAD+, SS-31).
